Rg3, as a treatment for breast cancer, suppresses the self-renewal of breast cancer stem cells by blocking Akt-mediated HIF-1α activation, thereby eliminating their stemness and inhibiting tumor proliferation (89). This evidence concerns the gene HIF1A and breast cancer.